Beligas Human Growth Hormones – 100IU

BPC-157 is a penta-decapeptide composed of 15 amino acids. It is a partial sequence of the body protection compound (BPC) that was discovered in and isolated from human gastric juice. Animal studies have shown it to accelerate the healing of many different wounds, including muscle, tendon and damaged ligaments. Additionally, BPC 157 has shown to protect organs and aids in the prevention of gastric ulcers. BPC-157 acts systemically in the digestive tract to combat leaky gut, IBS, gastro-intestinal cramps, and Crohn’s disease. This peptide has been known to exhibit analgesic characteristics. Research has shown its ability to help skin burns heal at a faster rate by increasing blood flow to damaged tissues. BPC-157 significantly accelerates reticulin and collagen formation as well as angiogenesis together with stimulation of macrophages and fibroblasts infiltration representing a potential therapeutic tool in wound healing management.

Copper peptide GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine with a strong affinity for copper(II).  It can also be found in human plasma, saliva, and urine. GHK-Cu is believed to work by binding to copper ions and activating various biological pathways, including the promotion of antioxidant activity, modulation of the immune response, and stimulation of cell proliferation and differentiation. There is good evidence that GHK-Cu is beneficial in wound healing, suppressing free-radical damage, increasing protein synthesis, fighting bacteria, and increasing the health of skin and fibroblasts. It has been found to stimulate collagen production, enhance wound healing, reduce scar formation, and improve skin elasticity. It has also been shown to have a positive effect on hair growth, bone density, and nerve regeneration.

PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone. It has been tested in clinical trials as a treatment for both male/female hypoactive sexual desire disorder and acute hemorrhage. PT-141 is an agonist for the melanocortin-4 and melanocortin-1 receptors. Research shows that it promotes sexual arousal and stimulates the immune system.